Adrenal Insufficiency Associated with long-term OCS Use. Prof Mark Gurnell

Adrenal Insufficiency Associated with long-term OCS Use.

Prof Mark Gurnell (Professor of Clinical Endocrinology) provides valuable insights into consequences of excess glucocorticoid exposure due to excess OCS exposure, hypothalamic-pituitary-adenal (HPA) axis dysfunction and the clinical features of adrenal insufficiency. Prof Gurnell also discusses an OCS dose tapering pathway, how to assess for adrenal insufficiency (AI) and supporting patients with AI.

Disclosures

Speaker’s bureau: AstraZeneca, GSK, Novartis. Advisory Board: AstraZeneca